43 DAFTAR PUSTAKA
1. Cancer. [internet] 2016. [cited 2016 April 14] Available from: http://www.who.int/cancer/en/
2. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. [internet] 2016. [cited 2016 April 14] Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx 3. Genes and human disease. [internet] 2016. [cited 2016 April 14] Available
from: http://www.who.int/genomics/public/geneticdiseases/en/index3.html 4th.ed. Lyon: International Agency for Research on Cancer; 2012. 14-7 7. Breast Cancer-American Cancer Society. [internet] 2016. [cited 2016
April 22] Available from: www.cancer.org>acs>cid>003090-pdf
8. Assi HA, Khoury KE, Dbouk H, et al. (2013) “Epidemiology and prognosis of breast cancer in young women”. Journal of Thoracic Disease. 5,(1),2-3
9. Allred C, Miller K, Viale G, Brogi E, Isola J. WHO Classification of Tumours of The Breast. 4th.ed. Lyon: International Agency for Research on Cancer; 2012. 22-3
10.Eroschenko VP. diFiore’s Atlas of Histology: with Functional Correlations. 11th.ed. United States of America: Lippincott Williams & Wilkins; 2008. 482-6
11.Mescher AL. JUNQUEIRA’S Basic Histology: TEXT & ATLAS.12th.ed.
United States of America: The McGraw-Hill Companies, Inc; 2010. 12.Martini FH, Nath JL, Bartholomew EF. Fundamentals of Anatomy &
Physiology. 9th.ed. United States of America: Pearson Education, Inc; 2012. 1062-4
13.Devita VT, Hellman TSL, Rosenberg SA. Devita, Hellman and
Rosenberg’s CANCER : Principles & Practice of Oncology. United States
of America: Lippincott Williams & Wilkins ; 2008
14.Bhat S. SRB’s Manual of Surgery. 4th.ed. New Delhi: Jaypee Brothers Medical Publisher (P) LTD; 2013. 563-5
15.Woodson AH, Profato JL, Muse KI, Litton JK. (2013) “Breast cancer in the young: role of the geneticist”. Journal of Thoracic Disease.5,(1), 19-26 16.Bharat A, Aft RL, Gao F, et al. Patient and tumor characteristics
associated with increased mortality in young women (< or =40 years) with breast cancer. J Surg Oncol 2009;100:248-51.
44
17.Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 2005;6:377-82.
18.Kollias J, Ellis IO, Elston CW, et al. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol 1999;25:584-9.
19.Dabbs DJ. Breast PATHOLOGY. 1st.ed. China : Elsevier Inc; 2012. 429-30
20.Ellis IO, Collins L, Ichihara S, MacGrogan G. WHO Classification of Tumours of The Breast. 4th.ed. Lyon: International Agency for Research on Cancer; 2012. 34-8
21.Benson JR, Gui G, Tuttle TM. EARLY Breast Cancer: From Screening to Multidisciplinary Management. Boca Raton. Taylor & Francis Group; 2013. 269
22.Breast Cancer: What are the risk factors for breasts cancer. [internet] 4 April 2016 [cited 2016 May 13] Available from: http://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm
23.Wilson R, Britton P. WHO Classification of Tumours of The Breast. 4th.ed. Lyon: International Agency for Research on Cancer; 2012. 17-8 24.Christinat A, Lascio SD, Pagani O. Hormonal therapies in young breast
cancer patients: when, what and for how long?. Journal of Thoracic Disease. 2013; 5(1): 36-46
25.Treatments for Hormone-Receptor-Positive Breast Cancer. [internet] 22 Januari 2014. [cited 2016 May 22] Available from:
http://www.breastcancer.org/symptoms/diagnosis/hormone-status/treatment_hrpos
26.Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R. Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. Journal of Thoracic Disease. 2013; 5(1): 9-18
27.HER2 Status. [internet] 16 Mei 2016. [cited 2016 May 22] Available from: http://www.breastcancer.org/symptoms/diagnosis/her2
28.Jon Godwin, Samantha Hinsley, Ariel Zwenger. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. January 2015, pp. 2-6.
29.Hormone Receptor Status. [internet] 27 Januari 2016. [cited 2016 May 22]
Available from:
31.Collins LC, Marotti JD, Gelber S, et al. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 2012; 131:1061-6
45
32.Chan M, Chang MC, Gonzalez R, Lategan B, del Barco E, Vera-Badillo F, et al. Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer. PLoS ONE. 2015 July; 10(7): e0132449
33.Gross JM, Yee D. How does the estrogen receptor work?. Breast Cancer Res. 2002; 4: 62-4
34.Zhenlin Bai and Ronald Gust. Breast cancer, Estrogen Receptor and Ligands. Arch Pharm Chem Life Sci. 2009; 342: 133-49
35.Welboren W, Stunnenberg HG, Sweep FCGJ, Span PN. Identifying estrogen receptor target genes. Elsevier. 2007 September; 1(2): 138-43 36.Lange CA, Yee D. Progesterone and Breast Cancer. Womens Health
(Lond Engl). 2008 March; 4(2): 151-62
37.Gao X, Nawaz Z. Role of steroid receptor coactivators and corepressor of progesterone receptors in breast cancer. Breast Cancer Research. 2002; 4(5): 182-6
38.Li Y, Rosen JM. Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2005; 10(1):17-24.
39.Moasser MM. The Oncogen HER2; Its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene. 2007 October; 26(45): 6469-87
40.Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol. 2001; 3:785-92
41.Iqbal N, Iqbal N. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications. Hindawi Publishing Corporation. 2014: 1-9
42.Kartika I, Maulani H, Sulastri H, Yuwono. EKSPRESI PROTEIN HER-2/neu, STATUS RESEPTOR ESTROGEN DAN PROGESTERON PADA BERBAGAI DERAJAT KEGANASAN KARSINOMA PAYUDARA DUKTAL INVASIF WANITA USIA MUDA. Majalah Patologi. 2009 Januari; 18(1): 32-40
43.Thapa B, Singh Y, Sayami P, Shrestha U, Sapkota R, Sayami G. Breast Cancer in Young Women from a Low Risk Population in Nepal. Asian Pacific Journal of Cancer Prevention. 2013; 14(9): 5095-99
44.Gabriel C, Domchek S. Breast cancer in young women. BioMed Central. 2010; 12: 212
45.Lund M, Butler E, Hair B, Ward K, Andrews J, et al. Cancer. 2010: 2549-58
46.Devi C, Tang T, Corbex M. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia. International Journal of Cancer. 2012; 131: 2869-77
47.Cvetanovic A, Popovic L, Filipovic S, Trifunovic J, Zivkovic N, et al. Young age and pathological features predict breast cancer outcome – report from a dual Institution experience in Serbia. JBUON. 2015; 20(6): 1407-13
46
48.Recăreanu F, Simionescu C, Georgescu C, Pirici E. Ductal invasive
mammary carcinoma – Clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein. Romanian Journal of Morphology and Embryology. 2012; 52 (3 Suppl): 1059-64
49.Almasri N, Hamad M. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan. Breast Cancer Research. 2005 May; 7(7): 598-604
